Global Business Inroads tying India and Europe together

13 December 2023 09:43

GBI

Bangalore/New Delhi - The international consultancy Global Business Inroads, or GBI, is forging connections between Indian and European tech startups. At the Bengaluru Tech Summit and the Global Bio-India 2023 event, GBI has brought scores of European entrepreneurs in contact with Indian business leaders, policymakers, and investors.

Global Business Inroads, or GBI, has connected numerous Indian and European innovators in recent weeks. At the Bengaluru Tech Summit on December 1, GBI organized a panel discussion on European and Indian collaboration opportunities, including partnerships between startups in both regions and regulations and policies that might affect such partnerships.

The panelists included, among others, Dharanidharan Sivasamy (FDI Officer, Consulate General of Belgium), Hemang Tanna (Senior Advisor, Innovation Projects ACCIO, Government of Catalonia), and, Saikiran Vedula (Country Manager, India Invest Northern Ireland), as well as Global Business Inroads Director Leena Pishe Thomas who is also Member of Board Deeptech Plovdiv Innovation Valley.

From December 4 to 6, GBI partnered with the Biotechnology Industry Research Assistance Council, or BIRAC, and Indian government agencies to bring five global startups to the Global Bio-India 2023 event in New Delhi, according to a press release issued December 6.

The startups include Hungarian water conservation firm Water&Soil, Dutch biocatalyst maker Gecco Biotech, Sri Lankan gene sequencer UKCAS Cultural Innovation, Brazilian bioscreener Crop BioLabs, and Romanian cell reprogrammer Genera Smart Lab.

“This is a unique opportunity…[for] international start-ups who generally don’t have access to information on markets like India and how to navigate and penetrate one of the fastest growing economies,” said Global Business Inroads Director Leena Pishe Thomas. “GBI has built a network, platform, and process to create access to technologies and enable more deployment.

Investment in India’s biotech industry hit $92.3 billion in 2022. The sector is expected to grow steadily to $150 billion by 2025 and $300 billion by 2030. Foreign investment and domestic innovation will fuel that growth, said BIRAC Managing Director Jitendra Kumar.

"The true potential of biotechnology lies in transcending geographical boundaries,” said Kumar. “BIRAC's endeavor to bring these international startups to India reflects our commitment to harnessing global expertise for mutual growth.” ce/jd
 

Previous newsletters